NASDAQ: VERV Lawsuit ALERT: Investors Who Lost Money With Shares of Verve Therapeutics, Inc. (NASDAQ: VERV) Should Contact the Shareholders Foundation
SAN DIEGO, CA, September 5, 2024 (Newswire.com) - A lawsuit was filed for certain investors in Verve Therapeutics, Inc. (NASDAQ:VERV) shares. Investors in NASDAQ: VERV shares should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in Verve Therapeutics, Inc. (NASDAQ:VERV) shares.
Investors that purchased shares of Verve Therapeutics, Inc. (NASDAQ: VERV) have certain options and for certain investors are short and strict deadlines running. Deadline: October 28, 2024. NASDAQ: VERV investors should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
On August 27, 2024, a lawsuit was filed by an investor in NASDAQ: VERV shares against Verve Therapeutics, Inc. over alleged securities laws violations. The plaintiff alleged that the defendants made false and/or misleading statements and/or failed to disclose, among other things, that defendants did not fully disclose the circumstances under which the Heart-1 Phase 1b clinical trial (the "Heart-1 Trial") of VERVE-101 would be halted (VERVE-101 is an investigational gene editing medicine designed to be a single course treatment that permanently turns off the PCSK9 gene in the liver to reduce disease-driving low-density lipoprotein cholesterol (LDL-C)), that the defendants overstated the potential benefits of its proprietary lipid nanoparticle (LNP) delivery system, and that as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times
Those who purchased Verve Therapeutics, Inc. (NASDAQ: VERV) shares should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
[email protected]
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
Contact Information
Michael Daniels
Manager
[email protected]
858-779-1554
SOURCE: Shareholders Foundation, Inc.
Source: Shareholders Foundation, Inc.
Share:
Tags: class action, lawsuit, NASDAQ: VERV, Verve Therapeutics